Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 16 of 136 for:    (domestic or partner) AND (violence OR abuse)

Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01958554
Recruitment Status : Completed
First Posted : October 9, 2013
Last Update Posted : September 29, 2015
Sponsor:
Collaborator:
NMP Medical Research Institute
Information provided by (Responsible Party):
Macmillan Research Group UK

Brief Summary:
Intimate partner violence (IPV) against women have negative mental health consequences for survivors; interventions designed to improve survivors' depressive symptoms and health status are limited.Present study evaluate the effectiveness of an integrated intervention in reducing intimate partner violence (IPV) improving health status.

Condition or disease Intervention/treatment Phase
Domestic Violence Behavioral: Intervention Group Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomised Controlled Trial of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence
Study Start Date : October 2013
Actual Primary Completion Date : March 2014
Actual Study Completion Date : June 2014

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention Group
The integrated intervention consisted of 12 week of program and group support, based on the freedom program by pet craven. The former component was provided covering beliefs held and tactics used by the domestic violence abusers and took about 45 minutes. It included protection and enhanced choice-making and problem-solving skills.
Behavioral: Intervention Group
No Intervention: Wait list control group
The group was listed in wait list and were offered the same intervention and support on completion of study period.



Primary Outcome Measures :
  1. Depression [ Time Frame: Change from Baseline in Beck Depression Inventory at 12 weeks ]

Secondary Outcome Measures :
  1. Health Related Quality of Life [ Time Frame: Change from baseline in SF-36 at 12 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women over 18
  • For those who agreed to participate
  • Given written consent
  • Screening for abuse was positive

Exclusion Criteria:

  • Screened Negative
  • serious mental condition including suicide, hallucination, Dementia
  • Drug or substance abuse, alcoholism
  • Pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01958554


Locations
Layout table for location information
India
Sonal Foundation
Mahesana, Gujarat, India, 384001
Sponsors and Collaborators
Macmillan Research Group UK
NMP Medical Research Institute
Investigators
Layout table for investigator information
Study Director: Bharat Chaudhari, MA Sonal Foundation, India
Study Chair: Neha sharma, PhD Macmillan Research Group

Layout table for additonal information
Responsible Party: Macmillan Research Group UK
ClinicalTrials.gov Identifier: NCT01958554     History of Changes
Other Study ID Numbers: Mac/NMP 0917
First Posted: October 9, 2013    Key Record Dates
Last Update Posted: September 29, 2015
Last Verified: September 2015